See All Slides - tctmd.com

Slides

Presentation TCT 2012

Choice of Antiplatelet Therapies in ACS/STEMI

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Two Distal Left Main Trifurcation Cases: My Solutions

Presenter: Antonio Colombo

October 22, 2012

Presentation TCT 2012

REDUCE Trial Update

Presenter: John Rhodes

October 22, 2012

Presentation TCT 2012

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES

Presenter: Ted Feldman

October 22, 2012

Presentation TCT 2012

Ostial Left Main Disease: Techniques to "Nail" the Ostium

Presenter: Andrejs Erglis

October 22, 2012

Presentation TCT 2012

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Presenter: Neil Weissman

October 22, 2012

Presentation TCT 2012

Intentional Risk “Drift” vs. Refinement in Risk Assessment: Data from SOURCE and Personal Experiences

Presenter: Martyn Thomas

October 22, 2012

Presentation TCT 2012

Step 7: Funding Opportunities

Presenter: Rick Anderson

October 22, 2012

Presentation TCT 2012

Retrograde Coronary Injection: Current and Evolving Status

Presenter: Amit Patel

October 22, 2012

Advertisement

Slides

Choice of Antiplatelet Therapies in ACS/STEMI

Two Distal Left Main Trifurcation Cases: My Solutions

REDUCE Trial Update

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES

Ostial Left Main Disease: Techniques to "Nail" the Ostium

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Intentional Risk “Drift” vs. Refinement in Risk Assessment: Data from SOURCE and Personal Experiences

Step 7: Funding Opportunities

Retrograde Coronary Injection: Current and Evolving Status

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content